Biogen to present Phase 2 Alzheimer's drug data at AAIC 2026

June 29, 2026 6:59 AM

Biogen Inc. (Nasdaq: BIIB) will present data from its Alzheimer's disease portfolio at the Alzheimer's Association International Conference (AAIC) 2026 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found